Abiopharma

🔍 EDGEMOND JAMES (Executive)

Company: UNITED THERAPEUTICS Corp (UTHR)

Report Date: 2026-04-30

Detailed Transactions and Holdings:

• Acquired 10,000 shares of Common Stock at $135.42 per share (Direct)
  Date: 2026-04-30 | Code: M | equity_swap_involved: false | shares_owned_after: 28,876.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 262 shares of Common Stock at $569.2437 per share (Direct)
  Date: 2026-04-30 | Code: S | equity_swap_involved: false | shares_owned_after: 28,614.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 484 shares of Common Stock at $570.1912 per share (Direct)
  Date: 2026-04-30 | Code: S | equity_swap_involved: false | shares_owned_after: 28,130.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 2,940 shares of Common Stock at $571.2313 per share (Direct)
  Date: 2026-04-30 | Code: S | equity_swap_involved: false | shares_owned_after: 25,190.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 3,034 shares of Common Stock at $572.0028 per share (Direct)
  Date: 2026-04-30 | Code: S | equity_swap_involved: false | shares_owned_after: 22,156.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 880 shares of Common Stock at $573.0046 per share (Direct)
  Date: 2026-04-30 | Code: S | equity_swap_involved: false | shares_owned_after: 21,276.00 | transaction_form_type: 4 | Footnotes: F1, F6
• Sold 887 shares of Common Stock at $574.0653 per share (Direct)
  Date: 2026-04-30 | Code: S | equity_swap_involved: false | shares_owned_after: 20,389.00 | transaction_form_type: 4 | Footnotes: F1, F7
• Sold 273 shares of Common Stock at $574.9643 per share (Direct)
  Date: 2026-04-30 | Code: S | equity_swap_involved: false | shares_owned_after: 20,116.00 | transaction_form_type: 4 | Footnotes: F1, F8
• Sold 486 shares of Common Stock at $576.2407 per share (Direct)
  Date: 2026-04-30 | Code: S | equity_swap_involved: false | shares_owned_after: 19,630.00 | transaction_form_type: 4 | Footnotes: F1, F9
• Sold 336 shares of Common Stock at $577.2372 per share (Direct)
  Date: 2026-04-30 | Code: S | equity_swap_involved: false | shares_owned_after: 19,294.00 | transaction_form_type: 4 | Footnotes: F1, F10
• Sold 378 shares of Common Stock at $578.0696 per share (Direct)
  Date: 2026-04-30 | Code: S | equity_swap_involved: false | shares_owned_after: 18,916.00 | transaction_form_type: 4 | Footnotes: F1, F11
• Sold 40 shares of Common Stock at $578.76 per share (Direct)
  Date: 2026-04-30 | Code: S | equity_swap_involved: false | shares_owned_after: 18,876.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 10,000 shares of Stock Option at $135.42 per share (Derivative)
  Date: 2026-04-30 | Code: M | Expires: 2027-03-15 | Exercise: 2023-03-15 | equity_swap_involved: false | shares_owned_after: 42,500.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on October 31, 2025.
• F10: This transaction was executed in multiple trades at prices ranging from $576.75 to $577.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F11: This transaction was executed in multiple trades at prices ranging from $577.76 to $578.66. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F2: This transaction was executed in multiple trades at prices ranging from $568.58 to $569.48. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F3: This transaction was executed in multiple trades at prices ranging from $569.58 to $570.57. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F4: This transaction was executed in multiple trades at prices ranging from $570.61 to $571.57. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F5: This transaction was executed in multiple trades at prices ranging from $571.61 to $572.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F6: This transaction was executed in multiple trades at prices ranging from $572.61 to $573.40. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F7: This transaction was executed in multiple trades at prices ranging from $573.61 to $574.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F8: This transaction was executed in multiple trades at prices ranging from $574.61 to $575.57. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F9: This transaction was executed in multiple trades at prices ranging from $575.73 to $576.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.